Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaba
Completed
- Conditions
- Deep vein thrombosisCirculatory System
- Registration Number
- ISRCTN18090286
- Lead Sponsor
- Japanese National Hospital Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1. Adults aged 20 and over
2. Undergoing knee replacement surgery for primary joint disease, including osteoarthritis (OA) and rheumatoid arthritis (RA)
Exclusion Criteria
1. Presence of predefined risk factors for bleeding, coagulation disorders, heart failure (New York Heart Association class III or IV), significant renal dysfunction (creatinine clearance <30?mL/min)
2. Abnormalities in biochemical measurements (aspartate aminotransferase or alanine aminotransferase =5 times the upper limit of normal or total bilirubin =2 times the upper limit of normal)
3. Those scheduled to undergo bilateral joint replacement or reoperation
4. Unable to walk
5. Uncontrolled cardiovascular disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Symptomatic DVT rate is detected by ultrasonography at baseline and 10 days postoperative<br>2. Non-symptomatic DVT rate is detected by ultrasonography at baseline and 10 days postoperative<br>3. Fatal/nonfatal pulmonary embolism (PE) rate is detected by computed tomography at baseline and 28 days postoperative
- Secondary Outcome Measures
Name Time Method o secondary outcome measures